Up-regulated biglycan expression correlates with the malignancy in human colorectal cancers

Clinical and Experimental Medicine

Volumn 12, Issue 3, 2012, Pages 195-199

  Gu, Xiaohu ^a   Ma, Yegang ^a   Xiao, Jingdong ^b   Zheng, Hongxin ^b   Song, Chun ^a   Gong, Yuehua ^c   Xing, Xiaojing ^a  

^a LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

^b LIAONING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Biglycan; Colorectal cancer; Malignancy; Quantitative real time RT PCR

Indexed keywords

BIGLYCAN; MESSENGER RNA;

ADULT; ARTICLE; CANCER TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; UPREGULATION;

ADULT; AGED; BIGLYCAN; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MALE; MIDDLE AGED; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84865464893     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-011-0155-4     Document Type: Article

References (23)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 2 74 108 55/2/74 15761078 10.3322/canjclin.55.2.74
2. YL Zhang ZS Zhang BP Wu DY Zhou 2002 Early diagnosis for colorectal cancer in China World J Gastroenterol 8 1 21 25 11833064
3. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin 59 4 225 249 10.3322/caac.20006 19474385 10.3322/caac.20006
4. T Tanaka 2009 Colorectal carcinogenesis: review of human and experimental animal studies J Carcinog 8 5 19332896 10.4103/1477-3163.49014
5. C Frantz KM Stewart VM Weaver 2010 The extracellular matrix at a glance J Cell Sci 123 Pt 24 4195 4200 10.1242/jcs.023820 21123617 10.1242/jcs.023820 1:CAS:528:DC%2BC3MXhtV2qsr4%3D
6. M Gulyas K Dobra A Hjerpe 1999 Expression of genes coding for proteoglycans and Wilms' tumour susceptibility gene 1 (WT1) by variously differentiated benign human mesothelial cells Differentiation 65 2 89 96 10.1046/j.1432-0436.1999.6520089.x 10550542 1:CAS:528:DyaK1MXnvFCis7g%3D
7. M Gotte DD Sofeu Feugaing H Kresse 2004 Biglycan is internalized via a chlorpromazine-sensitive route Cell Mol Biol Lett 9 3 475 481 15332124
8. MF Young Y Bi L Ameye XD Chen 2002 Biglycan knockout mice: new models for musculoskeletal diseases Glycoconj J 19 4-5 257 262 10.1023/A: 10253361143525142004 12975603 10.1023/A:1025336114352 1:CAS:528: DC%2BD3sXmsFWit70%3D
9. R Nishino M Honda T Yamashita H Takatori H Minato Y Zen M Sasaki H Takamura K Horimoto T Ohta Y Nakanuma S Kaneko 2008 Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma J Hepatol 49 2 207 216 10.1016/j.jhep.2008.03.025 18490072 10.1016/j.jhep.2008.03.025 1:CAS:528:DC%2BD1cXotlWqsbc%3D
10. S Pan L Cheng JT White W Lu AG Utleg X Yan ND Urban CW Drescher L Hood B Lin 2009 Quantitative proteomics analysis integrated with microarray data reveals that extracellular matrix proteins, catenins, and p53 binding protein 1 are important for chemotherapy response in ovarian cancers OMICS 13 4 345 354 10.1089/omi.2009.0008 19422301 10.1089/omi.2009.0008 1:CAS:528: DC%2BD1MXht1CjurnF
11. F Modolo MT Biz MT Martins SO Machado de Sousa NS de Araujo 2010 Expression of extracellular matrix proteins in adenomatoid odontogenic tumor J Oral Pathol Med 39 3 230 235 10.1111/j.1600-0714.2009.00846.x 20070486 10.1111/j.1600-0714.2009.00846.x 1:CAS:528:DC%2BC3cXksVKgu7c%3D
12. Mikula M, Rubel T, Karczmarski J, Goryca K, Dadlez M, Ostrowski J (2010) Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors. Funct Integr Genomics. doi: 10.1007/s10142-010- 0200-5
13. CK Weber G Sommer P Michl H Fensterer M Weimer F Gansauge G Leder G Adler TM Gress 2001 Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines Gastroenterology 121 3 657 667 S0016508501397688 11522750 10.1053/gast.2001.27222 1:CAS:528: DC%2BD3MXntVKnsbk%3D
14. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 4 402 408 10.1006/meth.2001.1262S1046-2023(01)91262-9 11846609 10.1006/meth.2001.1262 1:CAS:528:DC%2BD38XhtFelt7s%3D
15. F Wu A Shirahata K Sakuraba Y Kitamura T Goto M Saito K Ishibashi G Kigawa H Nemoto Y Sanada K Hibi 2010 Down-regulation of Mus81 as a potential marker for the malignancy of gastric cancer Anticancer Res 30 12 5011 5014 30/12/5011 21187482
16. K Sakuraba K Yokomizo A Shirahata T Goto M Saito K Ishibashi G Kigawa H Nemoto K Hibi 2011 TIP60 as a potential marker for the malignancy of gastric cancer Anticancer Res 31 1 77 79 31/1/77 21273583 1:CAS:528:DC%2BC3MXisVanu74%3D
17. A Shirahata W Fan K Sakuraba K Yokomizo T Goto H Mizukami M Saito K Ishibashi G Kigawa H Nemoto Y Sanada K Hibi 2011 MACC 1 as a Marker for Vascular Invasive Hepatocellular Carcinoma Anticancer Res 31 3 777 780 31/3/777 21498695
18. K Woolfson 1991 Tumor markers in cancer of the colon and rectum Dis Colon Rectum 34 6 506 511 2036931 10.1007/BF02049939 1:STN:280:DyaK3M3ktlGltw%3D%3D
19. JM Rhodes 1999 Usefulness of novel tumour markers Ann Oncol 10 suppl 4 118 121 10436801 10.1093/annonc/10.suppl-4.S118
20. E Tan N Gouvas RJ Nicholls P Ziprin E Xynos PP Tekkis 2009 Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer Surg Oncol 18 1 15 24 10.1016/j.suronc.2008.05.008 18619834 10.1016/j.suronc.2008.05.008
21. O Galamb F Sipos S Spisak B Galamb T Krenacs G Valcz Z Tulassay B Molnar 2009 Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes Cell Oncol 31 1 19 29 19096147 1:CAS:528:DC%2BD1cXhsFSmt7bP
22. DD Fang YJ Kim CN Lee S Aggarwal K McKinnon D Mesmer J Norton CE Birse T He SM Ruben PA Moore 2010 Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery Br J Cancer 102 8 1265 1275 10.1038/sj.bjc.6605610 20332776 10.1038/sj.bjc.6605610 1:CAS:528:DC%2BC3cXksFOltr0%3D
23. GW Yip M Smollich M Gotte 2006 Therapeutic value of glycosaminoglycans in cancer Mol Cancer Ther 5 9 2139 2148 10.1158/1535-7163.MCT-06-0082 16985046 10.1158/1535-7163.MCT-06-0082 1:CAS:528:DC%2BD28Xps1ynsrY%3D